Skip to main content
Log in

Duration of antibiotic therapy in pyelonephritis: when shorter is better

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Czaja CA, Scholes D, Hooton TM, Stamm WE (2007) Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 45(3):273–280

    Article  Google Scholar 

  2. Nicolle LE (2001) Epidemiology of urinary tract infection. Infect Med 18:153–162

    Google Scholar 

  3. Montano N, Costantino G, Casazza G et al (2016) The Italian Society of Internal Medicine choosing wisely campaign. Intern Emerg Med 11(8):1125–1130. https://doi.org/10.1007/s11739-016-1560-1

    Article  PubMed  Google Scholar 

  4. Choosing Wisely. Index @ www.choosingwisely.org. https://www.choosingwisely.org/

  5. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE (1999) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. IDSA Clin Infect Dis. 29(4):745–758. https://doi.org/10.1086/520427

    Article  CAS  PubMed  Google Scholar 

  6. Kranz J, Schmidt S, Lebert C et al (2018) The 2017 Update of the German clinical guideline on epidemiology, diagnostics, therapy, prevention, and management of uncomplicated urinary tract infections in adult patients part II: therapy and prevention. Urol Int. 100(3):271–278. https://doi.org/10.1159/000487645

    Article  PubMed  Google Scholar 

  7. Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–e120. https://doi.org/10.1093/cid/ciq257

    Article  PubMed  Google Scholar 

  8. Bonkat G, Pickard R, Bartoletti R, et al. EAU Guidelines on Urological Infections. 2017

  9. Erba L, Furlan L, Monti A et al (2020) Short vs long-course antibiotic therapy in pyelonephritis: a comparison of systematic reviews and guidelines for the SIMI choosing wisely campaign. Intern Emerg Med. https://doi.org/10.1007/s11739-020-02401-4

    Article  PubMed  Google Scholar 

  10. Kyriakidou KG, Rafailidis P, Uk M, Matthaiou DK, Athanasiou S, Falagas ME (2008) Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials. Clin Ther 30(10):1859–1868. https://doi.org/10.1016/S0149-2918(08)00328-7

    Article  CAS  PubMed  Google Scholar 

  11. Eliakim-Raz N, Yahav D, Paul M, Leibovici L (2013) Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection— 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 68(10):2183–2191. https://doi.org/10.1093/jac/dkt177

    Article  CAS  PubMed  Google Scholar 

  12. Hanretty AM, Gallagher JC (2018) Shortened courses of antibiotics for bacterial infections: a systematic review of randomized controlled trials. Pharmacotherapy 38(6):674–687. https://doi.org/10.1002/phar.2118

    Article  PubMed  Google Scholar 

  13. Royer S, Demerle KM, Dickson RP, Prescott HC (2018) Shorter versus longer courses of antibiotics for infection in hospitalized patients: A systematic review and meta-analysis. J Hosp Med 13(5):336–342. https://doi.org/10.12788/jhm.2905

    Article  PubMed  PubMed Central  Google Scholar 

  14. Safrin S, Siegel D, Black D (1988) Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 85:793–798

    Article  CAS  Google Scholar 

  15. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB (1994) ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med 12:271–278

    Article  CAS  Google Scholar 

  16. Talen D, Stamm WE, Reuning-Scherer J, Church D. Ciprofloxacin (CIP) 7-day vs. TMP/SMX 14-day1/2ceftriaxone (CRO) for acute uncomplicated pyelonephritis: a randomized, double-blind trial. Boston: International Congress of Infectious Diseases,1998

  17. Bailey RR (1994) Duration of antimicrobial treatment and the use of drug combinations for the treatment of uncomplicated acute pyelonephritis. Infection 22(suppl 1):S50–S52

    Article  Google Scholar 

  18. Huang ES, Stafford RS (2002) National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 162(1):41–47. https://doi.org/10.1001/archinte.162.1.41

    Article  PubMed  Google Scholar 

  19. Kahan NR, Chinitz DPKE (2004) Longer than recommended empiric antibiotic treatment of urinary tract infection in women: An avoidable waste of money. J Clin Pharm Ther 29(1):59–63

    Article  CAS  Google Scholar 

  20. Gómez Belda AB, De la Fuente J, Diez LF et al (2019) Inadequate empirical antimicrobial treatment in older people with bacteremic urinary tract infection who reside in nursing homes: A multicenter prospective observational study. Geriatr Gerontol Int 19(11):1112–1117. https://doi.org/10.1111/ggi.13776

    Article  PubMed  Google Scholar 

  21. Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P (2009) Addressing the challenge of extendedspectrum beta-lactamases. Curr Opin Investig Drugs 10(2):172–180

    CAS  PubMed  Google Scholar 

  22. Oteo J, Pérez-Vázquez M, Campos J (2010) Extendedspectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23(4):320–326

    Article  CAS  Google Scholar 

  23. Rooney PJ, O’Leary MC, Loughrey AC et al (2009) Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 64(3):635–641

    Article  CAS  Google Scholar 

  24. Rodríguez-Baño J, Alcalá JC, Cisneros JM et al (2008) Community infections caused by extended-spectrum betalactamase-producing Escherichia coli. Arch Intern Med 168(17):1897–1902

    Article  Google Scholar 

  25. Gupta K (2002) Addressing antibiotic resistance. Am J Med 113(1A):29S–34S

    Article  Google Scholar 

  26. Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53–70

    Article  Google Scholar 

  27. Gelfand MS, Simmons BP, Craft RB, Grogan J, Amarshi N (1993) A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection. Am J Med 94(3A):126S–130S

    Article  CAS  Google Scholar 

  28. Stamm WE et al (1987) Treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks a randomized trial. Ann Intern Med 106(3):341–345

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Viazzi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

No informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Russo, E., Viazzi, F. Duration of antibiotic therapy in pyelonephritis: when shorter is better. Intern Emerg Med 16, 259–261 (2021). https://doi.org/10.1007/s11739-020-02440-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-020-02440-x

Navigation